• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices

    Simply Stimulating: Examining the Neurostimulation Sector

    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Tracey Technologies Upgrades iTrace Software

    Foster Corporation Rebrands its Distribution Business

    Greenleaf Health Recruits Two Former FDA Officials

    TOTAL Toric Contact Lenses for Astigmatism Debuts in Canada

    FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices

    Simply Stimulating: Examining the Neurostimulation Sector

    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Timeline Mystery for Updated EtO Rules

    An Update on Hospital Trends Post-Pandemic

    Don’t Fear the Audit: Benefits of Good Quality Practices

    Understanding the FDA’s Standards & Conformity Assessment Program

    Medtech Divestitures Are Good for Medtech Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    LEMO USA Inc.

    Providence Enterprise USA Inc.

    Cirtec Medical

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Designing for Manufacturing: 5 Common Startup Mistakes (and How to Avoid Them)

    5 Challenges Medtech Must Address to Transform Healthcare

    3D Printing Medical Devices Revolutionized Manufacturing

    5 Current Trends in Medical Device Security

    How Advanced Sensors Improve Design & Functionality of Respiratory Care Equipment
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    LEMO USA Inc.

    Providence Enterprise USA Inc.

    Cirtec Medical

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Pandemic has Accelerated Nearshoring Medtech Materials

    Buying materials from overseas may be cost-effective, but it can create an environment with less collaboration and less room for innovation.

    Pandemic has Accelerated Nearshoring Medtech Materials
    Image courtesy of Boyd Technologies.
    Michael Barbella, Managing Editor08.06.21
    Materials science has played a key role in the global battle against COVID-19.
     
    Triiodide, salt, copper, nano-silver, polyimide, and graphene are just a few of the recruits drafted thus far in the 18-month coronavirus war. Sodium chloride, a natural anti-bacterial agent, is adept at filtering air and decontaminating surfaces, while copper “foam” can effectively capture tiny aerosol droplets carrying virus particles (diameters between 0.1 and 0.4 micrometers). Moreover, graphene has been used as a protective coating on face masks (the material’s sharp edges damage viruses), and Vyon porous plastic filters are helping a University of Cambridge (U.K.) spinout company diagnose COVID-19 infections in less than 90 minutes.
     
    A research team at Northeastern University, meanwhile, has adopted a virus “mentality” to defeat SARS-CoV-2. The institution’s “Nano-Medicine Lab” created an injectable nano-molecular material that could prevent bacterial infection spread and also help reduce inflammation.
     
    “What we are creating in the lab are molecules that are about 80,000 times smaller than the diameter of a strand of your hair,” Thomas Webster, the lab’s head, said in an interview posted on the school’s website. “In order to kill the viruses, you have to make a nano-meter material to disrupt their function.”
     
    The technology Webster’s lab is researching as a potential coronavirus weapon actually was developed eight years ago as an injectable to help regenerate tissue and cartilage. The material was licensed by Concord, Mass.-based Audax Medical Inc. and has been commercialized for several regenerative medicine applications.
     
    “We quickly hypothesized, when this COVID-19 situation came up,” Webster explained, “that these molecules are great at healing tissue, they’re great at reducing infections, exceptional at inhibiting inflammation that often comes from microbes, and perhaps it could be used to kill viruses.”
     
    Such hypotheses were not uncommon over the last year as scientists, virologists, and medical professionals frantically searched for COVID-19’s molecular Achilles Heel. The pandemic, in fact, underscored the importance of materials science in developing tools and technologies for anti-viral research and treatment.
     
    MPO’s March feature, Resourceful Resources, details the various pandemic response efforts of more than a half-dozen materials suppliers and manufacturers. The story also examines the challenges associated with developing wearable materials, and the impact AI and digital health has had on the space. Matt Boyd, chief commercial officer, Priya George, development engineer, and Brianna Schaeffer, vice president of Program Management at Boyd Technologies, were among the experts interviewed for the story. Their full input is provided in the following Q&A.
     
    Michael Barbella: How is digital health and AI impacting the development of medical device materials? Has it changed the kind of materials developed/used in devices?
    Matt Boyd: Regarding digital health, smart devices are the key application because they are enabled by connectivity. For example, they can have batteries built into them or electronics printed on them; they can maintain their flexibility while holding a current, storing, and exchanging power; and they can signal, whether with Bluetooth or RFID or another wireless technology. Digital health has asked for miniaturization and flexibility to be built into flexible materials. You can put any sensor you want into materials, and it will communicate the results.
    Wearables aren’t only stick to skin devices, either. It can be a wrist band, implant, or garment with sensors woven to communicate with a platform. Remote patient monitoring is a better term to describe this field. It’s not just someone wearing a smartwatch but a patient with chronic medical conditions.
    For example, FreMon Scientific, a partner of Boyd Technologies, developed a smart, single-use bag that senses temperature as it thaws and then communicates to the practitioner, letting them know the sample is ready. On the biotech side of things, bioreactor bags now have sensors built into the bag’s side that read through the material and monitor the temperature of the contents so that you don’t have invasive probes potentially contaminating the product.
     
    Barbella: What material challenges are associated with developing wearable products and how can these hurdles be overcome?
    Priya George: Stick to skin materials continue to evolve in popularity. Still, there are significantly more limitations on materials that go directly on human skin versus those that do not require prolonged human contact. If a medical grade material is necessary, it will increase the price. Material costs and sourcing challenges increase even more significantly when using pharmaceutical grade materials because the quality requirements are much more stringent.
    Brianna Schaeffer: We have also been challenged with securing rigid devices to flexible materials. Integrating devices that monitor and communicate real-time results onto a flexible material that comes on a roll can present design challenges. It takes significant collective, creative troubleshooting to come up with a functional solution. Collaboration between companies is essential to overcome these material hurdles.
     
    Barbella: In what ways has the global pandemic spurred material innovation?
    Boyd: The pandemic revealed that so many materials are made outside the U.S., or if they are made domestically, the capacity is very limited. Nearshoring was already a focus of big OEMs, but it has accelerated since the pandemic began. The reason this impacts innovation is the ecosystem component. When we can source materials from neighboring states, we gain a collaborative feedback loop, so we can connect actors in the ecosystem and create innovation in a more condensed timeframe. That is one of the lost opportunity costs that many players didn’t realize until the pandemic. Companies often buy materials from overseas because it’s the cheapest, but that creates an environment with less collaboration and less room for innovation as a result.
     
    Barbella: Organizations from outside the medtech industry pitched in at the start of the pandemic to help address the shortage of ventilators and PPE. What kind of impact did that have on the kinds of materials used for those products? Was/is there more flexibility with regard to the types of materials used for ventilators and PPE?
    Schaeffer: We received many calls early in the pandemic from companies looking to upgrade their quality systems. Maybe they made a meltblown fabric or geotextile layer used for another purpose initially but now wanted to increase quality and cleanliness standards to pivot and have the flexibility to provide a product that could go into a medical device. Many of these companies made very few changes to their existing lines, just some tweaks to thickness and basis weight, and had to flow materials through regulatory testing.
    Boyd: On the other hand, however, I think it was a significant risk for the medical market for a couple of reasons. First, these companies were taking from the limited supply of materials needed by those already in the industry and without the expertise and quality systems in place. It’s similar to how consumers were told not to buy N95 masks because nurses and healthcare providers critically needed them early in the pandemic. Some companies purchased meltblown and other materials used for PPE, then sold their products into the consumer market because they didn’t want to deal with regulatory aspects.
    Secondly, some of them used improper materials that were potentially dangerous to put on people’s faces. In one sense, it’s great that these companies had the inclination to help meet the demand for PPE, but there are many concerns about the safety and efficacy of products made when companies quickly enter into the regulated space if they don’t have the expertise to do so. The first three months of the pandemic were incredibly risky as a result. We ran in a razor-thin margin with PPE across the country, even here in Massachusetts, and there was a lot of potential for human harm. Luckily, this was minimal.
    As we advance, I think we’ll see a lot of large consumer companies and tech companies coming into this space. The increased popularity of wearables and remote patient monitoring will allow these companies to operate on the fringes of regulated markets in ways that have the potential to be hazardous to patients.
     
    Barbella: What lessons from the pandemic will materials developers/suppliers carry forward in a post-COVID-19 world?
    George: Nearshoring is certain to become a priority moving forward. Most U.S. manufacturers and distributors are looking for sources within the states for most, if not all, materials. Even if companies are not engaging U.S. partners, it has become essential to have second sources domestically to be more agile in the face of future supply chain risks.
     
    Barbella: With the growing importance of sustainability and recyclability in the industry, can medtech materials be made more sustainable? If so, how?
    Boyd: Yes, materials can be made sustainably, but I think the key to becoming more sustainable has more to do with your footprint as a manufacturer and less to do with using PLA or corn-based polymers to make a single-use bag. Our industry is very focused on sustainability and recyclability of materials where it suits the application. Still, our primary focus is our manufacturing footprint, on our facility’s inputs and outputs (including waste and wastewater), and our ongoing commitment to be more sustainable.
    Schaeffer: Nearshoring is an excellent way to increase sustainability in the industry from a global perspective. Using domestic materials drastically reduces our carbon footprint and contributes to the growth of U.S. manufacturers.
     
    Barbella: Please discuss an instance (example) of an innovative material solution(s) your company came up with to meet challenging customer requests.
    Boyd: At a high level, innovative material solutions are what we do. Clients come to us with product designs, and we come up with material and supplier solutions based on feature functionality, patient safety, and user needs. We work hard to provide innovative material solutions to our customers so they can be “best-to-market” with their product.
    Schaeffer: We aided Medline with the commercialization of DriGo-HP, a multi-functional skin fold management solution. It uses patented technology to wick moisture, reduce odor, and contains encapsulated hydrogen peroxide to reduce bacterial buildup. Functionality for this product required a unique textile with inherent wicking properties to be used as the substrate material. The material is then treated with two novel coatings—one of which aids in translocating moisture outside of the skinfold; the other slowly releases hydrogen peroxide, which prevents the buildup of bacteria.
    Related Searches
    • Materials
    Related Knowledge Center
    • Materials
    Suggested For You
    MEDICAL & BIOTECH MANUFACTURING MEDICAL & BIOTECH MANUFACTURING
    NTK Cutting Tools USA NTK Cutting Tools USA
    Nissha Medical Technologies Nissha Medical Technologies
    JK Medirise-Disposable Medical Device Company JK Medirise-Disposable Medical Device Company
    Critical Software Solutions Critical Software Solutions
    DDL Inc. DDL Inc.
    RAUMEDIC Inc. RAUMEDIC Inc.
    sfm medical devices GmbH sfm medical devices GmbH
    Teleflex Medical OEM Teleflex Medical OEM
    MBK Tape Solutions MBK Tape Solutions
    Simbex Simbex
    Hobson & Motzer Inc. Hobson & Motzer Inc.
    Achilles USA Achilles USA
    IMA Automation North America IMA Automation North America
    WESTPAK Inc. WESTPAK Inc.

    Related Literature / Brochures

    • MEDICAL & BIOTECH MANUFACTURING

      ISO 13485:2016 • FDA Registered

    • NTK Cutting Tools USA

      ...
      Melissa Singher, Senior Product Coordinator 11.18.22

    • Nissha Medical Technologies

      ...
      Amy Jeary, Market Development Manager 11.18.22


    • JK Medirise-Disposable Medical Device Company

      ...
      Ketan Munjani, Marketing Manager 11.17.22

    • Critical Software Solutions

      ...
      Allen Curtis, CTO 11.16.22

    Loading, Please Wait..

    Trending
    • Medinbox And Abbott Partner To Increase Efficiency In Electrophysiology Labs
    • Masimo Reveals Freedom Health-Tracking Smartwatch
    • FDA OKs FemDx Medsystems' FalloView Device
    • Getinge’s Cardiosave Faces CE-Certificate Suspension From TÜV SÜD
    • A New Approach To Post-Market Surveillance
    Breaking News
    • Tracey Technologies Upgrades iTrace Software
    • Foster Corporation Rebrands its Distribution Business
    • Greenleaf Health Recruits Two Former FDA Officials
    • TOTAL Toric Contact Lenses for Astigmatism Debuts in Canada
    • FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Sensing Technology Drives the Future of Medical Care
    • New and Developing Diabetes Technologies Offer 'Sweet Relief'
    • Discussing Matters of Substance in Medtech Materials
    • Medical Device Testers Are Caught Up in a Whirlwind
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Hyaluronic Acid Ingredient Linked to Antioxidant Benefits In Vitro
    Anita Johansen Appointed New CEO of Probi
    Kemin Human Nutrition & Health Acquires Oral Health Ingredient
    Coatings World

    Latest Breaking News From Coatings World

    PPG Names Rodolfo Ramirez GM, Packaging Coatings
    Sherwin-Williams Unveils High Performance Interior Marine Decking Systems
    AkzoNobel Appoints Ricardo Rosso as Pontiac Site Manager
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Tracey Technologies Upgrades iTrace Software
    Foster Corporation Rebrands its Distribution Business
    Greenleaf Health Recruits Two Former FDA Officials
    Contract Pharma

    Latest Breaking News From Contract Pharma

    ABL Names Stephanie Colloud GM and COO in Europe
    Catawba Research Names Andrew Silverman COO
    Evonik Begins Construction of $220M U.S. Facility for Pharmaceutical Lipids
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    MAC Revamps 'Back To MAC' Recycling Program
    Coty Names New Chief Commercial Officer for Prestige Division
    GK Launches Vegan Hair Styling Range
    Happi

    Latest Breaking News From Happi

    Actor, Model Evan Mock Introduces Vegan Genderless Skin Care Brand Good Weird to Beauty Market
    MAC Cosmetics Brings Back Improved ‘Back-To-MAC’ Takeback Program
    Sederma Introduces Active Ingredient to Address Pigment Disorders
    Ink World

    Latest Breaking News From Ink World

    INX International Makes Investment in Gooten
    Videojet Launches 1580 C Soft-Pigmented Contrast Printer
    Epson to Showcase Textile, Signage and Aqueous Printers at ISA 2023
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Loftware secures significant growth equity investment
    Avery Dennison’s atma.io adds new ChatGPT and AI features
    Reproflex3 wins regional business award
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Drylock Technologies Plants First trees in Drylock Forest
    A.Celli Group to Hold Open House
    Toray Awarded for Nanodesign Technology
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Report: No Complications With OssDsign Catalyst Graft
    FDA OKs Bioretec's RemeOs Bioresorbable Metal Trauma Screw
    First Clinical Use of Stryker’s Tornier Pyrocarbon Humeral Head
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Universal Display Sponsors, Presents at ICDT 2023
    Miron Washington Joins Impinj Board of Directors
    All-Time High for Global 300MM Semiconductor Capacity in 2026: SEMI

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login